Skip to Content

TRUST EARNED THROUGH PROOF, NOT PROMISES.

Sponsors choose Biorasi for a proven record of delivering exactly what’s promised — with transparency, integrity, and precision at every stage of the trial.

REQUEST A PROPOSAL

WHY BIORASI?

 

Why Biorasi

ReliabilityReliability

Over 200 global studies executed, 5 FDA approvals in the past seven years, and a track record of delivering even in the most challenging scenarios.

Flexibility

Flexibility

Customizable operating models that scale to each trial, from first-in-human to global Phase III, without the bureaucracy that slows larger CROs.

Accessibility

Accessibility

Direct access to decision-makers, senior scientists, and real-time performance dashboards — no layers, no guesswork.

 

THE BIORASI ADVANTAGE

COMPETITIVE EDGE
OVER LARGER CROS

+
  • Leaner governance means faster pivots when protocols change or challenges arise.
  • Embedded “One Team” approach keeps decision-makers close to your study, not insulated by account layers.
  • Proven rescue expertise across $150M+ in recovered studies.

STANDING OUT
OVER NICHE CROs

+
  • Global site network across 48 countries, with AI-enhanced feasibility solutions..
  • Full-service capabilities — clinical operations, data sciences, medical affairs, and regulatory compliance — all under one coordinated team.
  • Specialized experience in innovative therapeutic areas: Dermatology, Oncology, Neurology, Nephrology, and Cell Therapy.

PROOF OF
PERFORMANCE

+
  • 200+ global studies executed
  • FDA approvals for therapies in Parkinson’s disease, autism spectrum disorder, C3G, IC-MPGN, and paroxysmal nocturnal hemoglobinuria (PNH)
  • 60% repeat sponsor rate
  • Studies conducted in 48 countries, reaching 65% of the global population

 

FROM OUR PARTNERS